Get the Stockscreener App
29.41
2.08%
0.60
Pre-market:
29.34
-0.07
-0.24%
Centene Corp stock is traded at $29.41, with a volume of 10.78M.
It is up +2.08% in the last 24 hours and up +5.45% over the past month.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
See More
Previous Close:
$28.81
Open:
$29.17
24h Volume:
10.78M
Relative Volume:
0.80
Market Cap:
$14.44B
Revenue:
$178.19B
Net Income/Loss:
$2.05B
P/E Ratio:
7.2797
EPS:
4.04
Net Cash Flow:
$1.08B
1W Performance:
+3.23%
1M Performance:
+5.45%
6M Performance:
-49.01%
1Y Performance:
-62.41%
1-Day Range:
$29.12
$29.62
1-Week Range:
$28.55
$30.17
52-Week Range:
$25.07
$80.59
Centene Corp Stock (CNC) Company Profile
Name
Centene Corp
Sector
Industry
Phone
(314) 725-4477
Address
7700 FORSYTH BLVD., ST LOUIS
Compare CNC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
29.41 | 14.24B | 178.19B | 2.05B | 1.08B | 4.04 |
|
UNH
Unitedhealth Group Inc
|
307.42 | 279.39B | 422.82B | 22.09B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
71.30 | 89.00B | 386.46B | 4.49B | 4.78B | 3.58 |
|
CI
Cigna Group
|
304.35 | 79.63B | 261.22B | 5.40B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
316.55 | 69.65B | 189.25B | 5.35B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
299.51 | 34.54B | 123.11B | 1.58B | 2.44B | 13.03 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-23-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Jul-16-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-10-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-02-25 | Downgrade | UBS | Buy → Neutral |
| Jun-09-25 | Resumed | Morgan Stanley | Overweight |
| Jun-02-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Apr-08-25 | Upgrade | Jefferies | Underperform → Hold |
| Feb-06-25 | Downgrade | Argus | Buy → Hold |
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Dec-13-24 | Upgrade | UBS | Neutral → Buy |
| Dec-10-24 | Downgrade | Jefferies | Hold → Underperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| Mar-21-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jan-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-05-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-20-23 | Initiated | UBS | Neutral |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-08-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-23-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-30-22 | Initiated | Argus | Buy |
| Aug-26-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-28-22 | Resumed | Barclays | Overweight |
| Jul-14-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-21-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Resumed | Bernstein | Outperform |
| May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-07-22 | Resumed | Barclays | Overweight |
| Jan-06-22 | Resumed | JP Morgan | Overweight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Dec-13-21 | Reiterated | BMO Capital Markets | Outperform |
| Dec-13-21 | Reiterated | BofA Securities | Buy |
| Dec-13-21 | Reiterated | Credit Suisse | Neutral |
| Dec-13-21 | Reiterated | Mizuho | Neutral |
| Dec-13-21 | Reiterated | Oppenheimer | Outperform |
| Dec-13-21 | Reiterated | Stephens | Overweight |
| Dec-13-21 | Reiterated | Truist | Buy |
| Dec-13-21 | Reiterated | Wells Fargo | Overweight |
| Dec-13-21 | Reiterated | Wolfe Research | Outperform |
| Nov-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Jul-09-21 | Initiated | Seaport Global Securities | Buy |
| May-19-21 | Initiated | Wells Fargo | Overweight |
| May-11-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-10-21 | Initiated | Mizuho | Neutral |
| Jan-21-21 | Resumed | Goldman | Neutral |
| Jan-15-21 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Feb-05-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-03-20 | Resumed | Evercore ISI | Outperform |
| Jan-28-20 | Reiterated | Bernstein | Outperform |
| Jan-06-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| May-10-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Oct-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Jul-18-18 | Resumed | Citigroup | Neutral |
| Dec-18-17 | Reiterated | Jefferies | Buy |
| Sep-13-17 | Reiterated | Leerink Partners | Mkt Perform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-22-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
| Mar-23-17 | Downgrade | Citigroup | Buy → Neutral |
| Feb-08-17 | Reiterated | Barclays | Overweight |
| Feb-07-17 | Resumed | Cantor Fitzgerald | Overweight |
| Jan-04-17 | Initiated | Piper Jaffray | Overweight |
View All
Centene Corp Stock (CNC) Latest News
Centene urges shareholders reject 'mini-tender' offer from Canadian investor - The Business Journals
CNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Centene Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Centene's Options Frenzy: What You Need to Know - Benzinga
CNC Lawsuit Alert! Class Action Lawsuit Against Centene Corporation - MSN
Centene Corporation (CNC) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Barchart.com
Centene Corporation Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds CNC Investors of Important Lead Plaintiff Deadline on September 8, 2025 - Barchart.com
Peach State Health Plan and the Medical College of Georgia at Augusta University Celebrate 2025 Peach State Scholars – Company AnnouncementFT.com - Financial Times
Centene Corporation Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before September 8, 2025 to Discuss Your RightsCNC - Barchart.com
Centene’s SWOT analysis: managed care giant faces market volatility - Investing.com
SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces A - GlobeNewswire
CNC Investors Have Opportunity to Lead Centene Corporation Securities Fraud Lawsuit with the Schall Law Firm - Barchart.com
CNC LOSSES: Centene Corporation Investors with Losses are Encouraged to Contact BFA Law before Expiration of September 8 Class Action Deadline - Newsfile
5 Stocks with the Largest Fair Value Estimate Cuts After Q2 Earnings - Morningstar
Centene Corporation Stock (CNC) Opinions on 2025 Guidance Withdrawal - Quiver Quantitative
5 S&P 500 Stocks with Low PE Ratios that May be Undervalued: Comcast, Centene, APA, Charter, Devon Energy - AInvest
Centene Corporation (CNC) Announces Board Changes Following Director Resignation - GuruFocus
Centene Corporation (CNC) Faces Shareholder Ire Amidst - GlobeNewswire
Undervalued Stocks in the S&P 500: 5 Low PE Ratio Picks to Consider - AInvest
Centene's 361st-Ranked Trading Volume, 28M Membership Surge, and Q2 Earnings Woes Spark Mixed Analyst Outlook - AInvest
Centene Corporation Nearing Breakout Level After BounceAnalyst Downgrade & Step-by-Step Trade Execution Guides - beatles.ru
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 8, 2025 in Centene LawsuitCNC - Barchart.com
Faruqi & Faruqi Investigates Claims on Behalf of Centene Investors - AInvest
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Centene - Barchart.com
Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know - Yahoo Finance
Investors in Centene Corporation (CNC): Protect Your RightsContact Levi & Korsinsky Before September 8, 2025 - The Globe and Mail
Deadline Alert: Centene Corporation (CNC) Investors Who - GlobeNewswire
When 90% Isn't an A+: Elevance's Cost Crunch and Carelon's Cushion - Yahoo Finance
Published on: 2025-08-13 21:36:12 - 선데이타임즈
CNC Q2 Deep Dive: Marketplace Risk Adjustment and Medicaid Cost Trends Challenge Profitability - Yahoo Finance
The 5 Most Interesting Analyst Questions From Centene’s Q2 Earnings Call - Yahoo Finance
How Aetna, Cigna, UnitedHealth stacked up in Q2 earnings - Modern Healthcare
CNC Stock News: Investors with Large Losses Should Contact Robbins LLP to Learn About Leading the Centene Corporation Class Action Lawsuit - Barchart.com
Centene, RadNet, Evolent Health, Illumina, and Charles River Laboratories Shares Are Soaring, What You Need To Know - Yahoo Finance
Shareholders that lost money on Centene Corporation(CNC) should contact Levi & Korsinsky about pending Class ActionCNC - PR Newswire
CENTENE INVESTORS: Contact BFA Law about the Centene Corporation (CNC) Class Action before the September 8 Legal Deadline - Newsfile
Centene Corporation shares rise 1.27% premarket after insider bought shares worth $490,365. - AInvest
CNC Investors Have Opportunity to Join Centene Corporation Fraud Investigation with the Schall Law Firm - Barchart.com
Centene Corporation Securities Fraud Lawsuit: Investors Must File by September 8, 2025 - AInvest
CNC Investors Have Opportunity To Lead Centene Corporation Securities Fraud Lawsuit - Barchart.com
When a Healthcare Giant Gets Sick: Elevance Health's 20% YTD Decline - Yahoo Finance
September 8, 2025 Deadline Approaching: Join Class Action Against Centene Corporation (CNC)Contact Levi & Korsinsky - The Globe and Mail
Investors in Centene Corporation Should Contact The Gross Law Firm Before September 8, 2025 to Discuss Your RightsCNC - Barchart.com
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
DJS Law Group Investigates Centene Corporation Securities Violations. - AInvest
One Big Beautiful Bill Act: A Boon or Bane for Centene? - MSN
Atlanta developer gears up project at University site owned by Centene - MSN
CNC COURT ALERT: Centene Corporation Investors are Notified the Class Action Deadline is Approaching and to Contact BFA Law before the September 8 Legal Deadline - Newsfile
Sanders urges rejection of Centene and Blue Cross health insurance rate hikes in Arkansas - Texarkana Gazette
Centene's Trading Volume Dives 23.58% to 338th Rank Amid Lawsuit Over Misleading Financial Disclosures as Shares Rise 1.31% - AInvest
Did You Lose Money on Centene Corporation (CNC)? Levi & Korsinsky Urges Investors to Act Before September 8, 2025 - Newsfile
Centene Corp Stock (CNC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):